| PEMOB35 | Addressing sexual health in trans masculinities: lessons learned from TransCITAR transgender cohort study in Argentina | Poster exhibition | Clinical issues in transgender people |
| EPD368 | Addressing the migrant gap: maternal healthcare perspectives on utilizing prevention of mother to child transmission (PMTCT) services during the COVID-19 pandemic, South Africa | E-poster | Migration and HIV |
| PESUD33 | Addressing the unique needs of learners living with HIV in the education setting | Poster exhibition | Interventions to reduce stigma and discrimination |
| EPB019 | Adherence and resistance to ART among postpartum women with HIV in KwaZulu-Natal, South Africa | E-poster | Viral load and CD4 monitoring |
| EPC025 | Adherence to antiretroviral therapy bymedication possession ratio and virological suppression among adolescents and young adults living with HIV on in Dar es Salaam, Tanzania: a retrospective cohort study | E-poster | Epidemiology of HIV in adolescents |
| EPC299 | Adherence to HIV treatment and prevention among a young Black and Latinx sexual minority men and transgender women cohort in the United States: PUSH study 2017-2021 | E-poster | Combination prevention strategies |
| EPD363 | Adherence to two HIV programs in a conflict-affected setting: lessons learnt from CAR | E-poster | Humanitarian crises and HIV |
| PEMOC38 | Adherence with antiretroviral therapy among recently pregnant HIV-positive women in 8 African countries | Poster exhibition | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC173 | Adherence, safety, and feasibility of HIV pre-exposure prophylaxis among adolescent men who have sex with men and transgender women in Brazil | E-poster | Demonstration and pilot projects for prevention (including PrEP, PEP, male circumcision) |
| PESUA14 | Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: impact on pharmacokinetics compared to VRC07-523LS administration alone | Poster exhibition | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |